[Seite 44↓]


Abbott, C. A.; Gorrell, M. D.; Kobayashi, Y.; Kawasaki, T.; Liddle, C.; Bishop, G. A. und McCaughan, G. W. (1995): Increased serum levels of dipeptidyl peptidase IV (CD26) in rats undergoing liver regeneration, Int Hepatol Commun 4) [3], Seite 165-174.

Arck, P. C.; Ferrick, D. A.; Steele-Norwood, D.; Egan, P. J.; Croitoru, K.; Carding, S. R.; Dietl, J. und Clark, D. A. (1999): Murine T cell determination of pregnancy outcome, Cell Immunol 196) [2], Seite 71-9.

Arck, P. C.; Merali, F. S.; Manuel, J.; Chaouat, G. und Clark, D. A. (1995): Stress-triggered abortion: inhibition of protective suppression and promotion of tumor necrosis factor-alpha (TNF-alpha) release as a mechanism triggering resorptions in mice, Am J Reprod Immunol 33) [1], Seite 74-80.

Arck, P. C.; Merali, F. S.; Stanisz, A. M.; Stead, R. H.; Chaouat, G.; Manuel, J. und Clark, D. A. (1995): Stress-induced murine abortion associated with substance P-dependent alteration in cytokines in maternal uterine decidua, Biol Reprod 53) [4], Seite 814-9.

Arndt, M.; Lendeckel, U.; Spiess, A. ; Faust, J.; Neubert, K.; Reinhold, D. und Ansorge, S. (2000): Dipeptidyl Peptidase IV (DPIV/CD26) mRNA Expression in PWM-Stimulated T-Cells Is Suppressed by Specific DP IV Inhibition, an Effect Mediated by TGF-beta(1)., Biochem Biophys Res Commun 274) [2], Seite 410-414.

Aster, J. C.; Kobayashi, Y.; Shiota, M.; Mori, S. und Sklar, J. (1992): Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients, Am J Pathol 141) [2], Seite 291-9..

Augustyns, K.; Bal, G.; Thonus, G.; Belyaev, A.; Zhang, X. M.; Bollaert, W.; Lambeir, A. M.; Durinx, C.; Goossens, F. und Haemers, A. (1999): The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors, Curr Med Chem 6) [4], Seite 311-27.

Bai, J. P. (1993): Distribution of brush-border membrane peptidases along the rabbit intestine: implication for oral delivery of peptide drugs, Life Sci 52) [11], Seite 941-7.

Bajorin, D.; Katz, A.; Chan, E.; Geller, N.; Vogelzang, N. und Bosl, G. J. (1988): Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies, J Clin Oncol 6) [5], Seite 786-92.

Barth, A. und Schulz, H. (1974): Untersuchungen und Charakterisierung der Dipeptidylpeptidase IV, Acta biologica et medica germanica 32), Seite 157-174.

Baum, C. M.; Weissman, I. L.; Tsukamoto, A. S.; Buckle, A. M. und Peault, B. (1992): Isolation of a candidate human hematopoietic stem-cell population, Proc Natl Acad Sci U S A 89) [7], Seite 2804-8.

Bauvois, B.; Sanceau, J. und Wietzerbin, J. (1992): Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor-alpha, Eur J Immunol 22) [4], Seite 923-30.

Bednarczyk, J. L.; Carroll, S. M.; Marin, C. und McIntyre, B. W. (1991): Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation, J Cell Biochem 46) [3], Seite 206-18.

Bennett, C. L.; Armitage, J. L. und Armitage, G. O. (1995): Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991, J Clin Oncol 13), Seite 969-973.

Bensinger, W. I.; Berenson, R. J.; Andrews, R. G.; Kalamasz, D. F.; Hill, R. S.; Bernstein, I. D.; Lopez, J. G.; Buckner, C. D. und Thomas, E. D. (1990): Positive selection of hematopoietic progenitors from marrow and peripheral blood for transplantation, J Clin Apheresis 5) [2], Seite 74-6.

Beutler, B.; Greenwald, D.; Hulmes, J. D.; Chang, M.; Pan, Y. C.; Mathison, J.; Ulevitch, R. und Cerami, A. (1985): Identity of tumour necrosis factor and the macrophage-secreted factor cachectin, Nature 316) [6028], Seite 552-4.

Beyer, J.; Bokemeyer, C.; Schmoll, H. J. und Siegert, W. (1994): Treatment intensification in disseminated germ-cell tumors, World J Urol 12) [4], Seite 207-13.

[Seite 45↓]

Beyer, J.; Kramar, A.; Mandanas, R.; Linkesch, W.; Greinix, A.; Droz, J.P.; Pico, J.L.; Diehl, A.; Bokemeyer, C.; Schmoll, H.J.; Nichols, C.R.; Einhorn, L.H. und W., Siegert (1996): High-Dose Chemotherapy as Salvage Treatment in Germ Cell Tumors: A Multivariate Analysis of Prognostic Factors, CJ Clin Oncol 14) [10], Seite 2638-2645.

Blanco, J.; Marie, I.; Callebaut, C.; Jacotot, E.; Krust, B. und Hovanessian, A. G. (1996): Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26, Exp Cell Res 225) [1], Seite 102-11.

Bongers, J.; Lambros, T.; Ahmad, M. und Heimer, E. P. (1992): Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs, Biochim Biophys Acta 1122) [2], Seite 147-53.

Bortin, M. M. (1970): A compendium of reported human bone marrow transplants, Transplantation 9) [6], Seite 571-587.

Bosl, G. J. (1993): Chemotherapy of germ cell tumors: current status and future directions, Eur Urol 23 Suppl 2), Seite 53-6.

Bosl, G.L. und Motzer, R.J. (1997): Testicular Germ-Cell Cancer (Review Article), N Engl J Med 337) [4], Seite 242-53.

Bostick, P. J.; Chatterjee, S.; Chi, D. D.; Huynh, K. T.; Giuliano, A. E.; Cote, R. und Hoon, D. S. (1998): Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients, J Clin Oncol 16) [8], Seite 2632-40.

Boulanger, L.; Roughly, P. und Gaudreau, P. (1992): Catabolism of rat growth hormone-releasing factor(1-29) amide in rat serum and liver, Peptides 13) [4], Seite 681-9.

Bouras, M.; Huneau, J. F. und Tome, D. (1996): The inhibition of intestinal dipeptidylaminopeptidase-IV promotes the absorption of enterostatin and des-arginine-enterostatin across rat jejunum in vitro, Life Sci 59) [25-26], Seite 2147-55.

Braun, S.; Pantel, K.; Muller, P.; Janni, W.; Hepp, F.; Kentenich, C. R.; Gastroph, S.; Wischnik, A.; Dimpfl, T.; Kindermann, G.; Riethmuller, G. und Schlimok, G. (2000): Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer, N Engl J Med 342) [8], Seite 525-33.

Bray, G. A. (1993): The nutrient balance hypothesis: peptides, sympathetic activity, and food intake, Ann N Y Acad Sci 676), Seite 223-41.

Brenner, M. K.; Rill, D. R.; Moen, R. C.; Krance, R. A.; Mirro, J.; Anderson, W. F und Ihle, J. N (1993): Gene-marking to trace origin of relapse after autologous bone marrow transplantation, Lancet 341), Seite 85.

Brown, J.; Greaves, M. F. und Molgaard, H. V. (1991): The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in haemopoietic cell lines, brain, and embryonic fibroblasts, Int Immunol 3) [2], Seite 175-184.

Brugger, W.; Bross, K.J.; Glatt, M.; Weber, F.; Mertelsmann, R. und Kanz, L. (1994): Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors, Blood 83) [3], Seite 636-640.

Campbell, R. M.; Stricker, P.; Miller, R.; Bongers, J.; Liu, W.; Lambros, T.; Ahmad, M.; Felix, A. M. und Heimer, E. P. (1994): Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences, Peptides 15) [3], Seite 489-95.

Chance, W. T. und Fischer, J. E. (1993): Neurotransmitters and food intake, Nutrition 9) [5], Seite 470-1.

Chaouat, G.; Menu, E.; Clark, D. A.; Dy, M.; Minkowski, M. und Wegmann, T. G. (1990): Control of fetal survival in CBA x DBA/2 mice by lymphokine therapy, J Reprod Fertil 89) [2], Seite 447-58.

Chen, C. H.; Stephens, R. L., Jr. und Rogers, R. C. (1997): PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC, Neurogastroenterol Motil 9) [2], Seite 109-16.

[Seite 46↓]

Civin, C. I.; Banquerigo, M. L.; Strauss, L. C. und Loken, M. R. (1987): Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow, Exp Hematol 15) [1], Seite 10-7.

Civin, C. I.; Trischmann, T.; Kadan, N. S.; Davis, J.; Noga, S.; Cohen, K.; Duffy, B.; Groenewegen, I.; Wiley, J.; Law, P.; Hardwick, A.; Oldham, F. und Gee, A. (1996): Highly purified CD34-positive cells reconstitute hematopoiesis, J Clin Oncol 14) [8], Seite 2224-33.

Clark, D. A.; Chaouat, G.; Arck, P. C.; Mittruecker, H. W. und Levy, G. A. (1998): Cytokine-dependent abortion in CBA x DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase, J Immunol 160) [2], Seite 545-9.

Cote, R. J.; Peterson, H. F.; Chaiwun, B.; Gelber, R. D.; Goldhirsch, A.; Castiglione-Gertsch, M.; Gusterson, B. und Neville, A. M. (1999): Role of immunohistochemical detection of lymph-node metastases in management of breast cancer: International Breast Cancer Study Group, Lancet 354) [9182], Seite 896-900.

Cote, R.J.; Rosen, P.P.; Lesser, M.L..; Old, L.J. und Osborne, M.P. (1991): Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases, J Clin Oncol 9), Seite 1749-56.

Dang, N. H.; Torimoto, Y.; Shimamura, K.; Tanaka, T.; Daley, J. F.; Schlossman, S. F. und Morimoto, C. (1991): 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation, J Immunol 147) [9], Seite 2825-32.

Dao, M.A. und Nolta, J.A. (2000): CD34: to select or not to select? That is the question, Leukemia 14) [5], Seite 773-776.

Darmoul, D.; Lacasa, M.; Baricault, L.; Marguet, D.; Sapin, C.; Trotot, P.; Barbat, A. und Trugnan, G. (1992): Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation, J Biol Chem 267) [7], Seite 4824-33.

Darmoul, D.; Voisin, T.; Couvineau, A.; Rouyer Fessard, C.; Salomon, R.; Wang, Y.; Swallow, D. M. und Laburthe, M. (1994): Regional expression of epithelial dipeptidyl peptidase IV in the human intestines, Biochem Biophys Res Commun 203) [2], Seite 1224-9.

De Meester, I.; Korom, S.; Van Damme, J. und Scharpe, S. (1999): CD26, let it cut or cut it down, Immunol Today 20) [8], Seite 367-75.

Deacon, C. F.; Hughes, T. E. und Holst, J. J. (1998): Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig, Diabetes 47) [5], Seite 764-9.

Decaens, C.; Rodriguez, P.; Bouchaud, C. und Cassio, D. (1996): Establishment of hepatic cell polarity in the rat hepatoma-human fibroblast hybrid WIF-B9. A biphasic phenomenon going from a simple epithelial polarized phenotype to an hepatic polarized one, J Cell Sci 109) [6], Seite 1623-1635.

Deisseroth, A. B.; Zu, Z.; Claxton, D.; Hanania, E. G.; Ellerson, D.; Goldberg, L.; Thomas, M.; Janicek, K.; Anderson, W. F.; Hester, J.; Körbling, M.; Durett, A.; Moen, R.; Berenson, R.; Heimfeld, S.; Hamer, J.; Calvert, L.; Tibbits, P.; Talpaz, M.; Kantarjian, H.; Champlin, R. und Reading, C. (1994): Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse, Blood 83), Seite 3068.

Diel, I.J.; Kaufmann, M.; Costa, S.S.; Holle, R.; von Minckwitz, G. und Solomayer, E.F. (1996): Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status, J Natl Cancer Inst 88), Seite 1652-8.

DiGiusto, D.; Chen, S.; Combs, J.; Webb, S.; Namikawa, R.; Tsukamoto, A.; Chen, B. P. und Galy, A. H. (1994): Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34, Blood 84) [2], Seite 421-32.

Dong, R.P. und Morimoto, C. (1996): Role of CD26 for CD4 memory T cell function and activation, Hum Cell 9) [3], Seite 153-162.

Durum, S. K.; Schmidt, J. A. und Oppenheim, J. J. (1985): Interleukin 1: an immunological perspective, Annu Rev Immunol 3), Seite 263-87.

[Seite 47↓]

Elovson, J. (1980): Biogenesis of plasma membrane glycoproteins. Tracer kinetic study of two rat liver plasma membrane glycoproteins in vivo, J Biol Chem 255) [12], Seite 5816-5825.

Ema, H.; Takano, H.; Sudo, K. und Nakauchi, H. (2000): In vitro self-renewal division of hematopoietic stem cells, J Exp Med 192) [9], Seite 1281-1288.

Erlanson Albertsson, C. und Larsson, A. (1988): The activation peptide of pancreatic procolipase decreases food intake in rats, Regul Pept 22) [4], Seite 325-31.

Fan, Y.; Einhorn, L.; Saxman, S.; Katz, B.; Abonour, R. und Cornetta, K. (1998): Detection of germ cell tumor cells in apheresis products using polymerase chain reaction, Clin Cancer Res 4) [1], Seite 93-8.

Faucher, C.; le Corroller, A. G. und Blaise, D. (1994): Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness, Bone Marrow Transplant 14), Seite 895-901.

Fina, L.; Molgaard, H. V.; Robertson, D.; Bradley, N. J.; Monaghan, P.; Delia, D.; Sutherland, D. R.; Baker, M. A. und Greaves, M. F. (1990): Expression of the CD34 gene in vascular endothelial cells, Blood 75) [12], Seite 2417-02426.

Fleischer, B. (1994): CD26 - a surface protease involved in T-cell activation., Immunol Today 15) [4], Seite 180-184.

Franco, R.; Valenzuela, A.; Lluis, C. und Blanco, J. (1998): Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes, Immunol Rev 161), Seite 27-42.

Franklin, W. A.; Shpall, E. J.; Archer, P.; Johnston, C. S.; Garza Williams, S.; Hami, L.; Bitter, M. A.; Bast, R. C. und Jones, R. B. (1996): Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support, Breast Cancer Res Treat 41) [1], Seite 1-13.

Fritsch, G.; Buchinger, P.; Printz, D.; Fink, F. M.; Mann, G.; Peters, C.; Wagner, T.; Adler, A. und Gadner, H. (1993): Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis, Blood 81) [9], Seite 2301-9.

Giere, R.N. (1988): Explaining science: a cognitive approach, The University of Chicago Press, Chicago, 0-226-29206-1.

Gonzalez Gronow, M. und Weber, M.R. (1998): Dipeptidyl peptidase IV (CD26) is a receptor for streptokinase on rheumatoid synovial fibroblasts, Fibrinolysis Proteolysis 12) [3], Seite 129-135.

Good, R. A.; Gatti, R. A.; Hong, R. und Meuwissen, H. J. (1969): Graft tratment of immunological deficiency, Lancet 1) [7606], Seite 1162.

Gotoh, H.; Hagihara, M.; Nagatsu, T.; Iwata, H. und Miura, T. (1989): Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in synovial fluid from patients with rheumatoid arthritis and osteoarthritis, Clin Chem 35) [6], Seite 1016-1018.

Grandt, D.; Dahms, P.; Schimiczek, M.; Eysselein, V. E.; Reeve, J. R., Jr. und Mentlein, R. (1993): Proteolytic processing by dipeptidyl aminopeptidase IV generates receptor selectivity for peptide YY (PYY), Med Klin 88) [3], Seite 143-5.

Gribben, J. G.; Freedman, A. S.; Neuberg, D.; Roy, D. C.; Blake, K. W.; Woo, S. D.; Grossbard, M. L.; Rabinowe, S. N.; Coral, F.; Freeman, G. J. und et al. (1991): Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma, N Engl J Med 325) [22], Seite 1525-33.

Habermas, J. (1981): Theorie kommunikativen Handelns, Suhrkamp, Frankfurt/M..

Hagihara, M.; Fujiwara, M. und Nagatsu, T. (1989): Activities of dipeptidyl peptidases in BXSB mice and MRL/lpr mice with lupus erythematosus-like syndrome, Biochem Med Metab Biol 42) [3], Seite 224-31.

Hansen, G. H.; Niels Christiansen, L. L.; Poulsen, M. D.; Noren, O. und Sjostrom, H. (1994): Distribution of three microvillar enzymes along the small intestinal crypt-villus axis, J Submicrosc Cytol Pathol 26) [4], Seite 453-60.

[Seite 48↓]

Hanski, C.; Huhle, T.; Gossrau, R. und Reutter, W. (1988): Direct evidence for the binding of rat liver DPP IV to collagen in vitro, Exp Cell Res 178), Seite 64-72.

Hanski, C.; Huhle, T. und Reutter, W. (1985): Involvement of plasma membrane dipeptidyl peptidase IV in fibronectin-mediated adhesion of cells on collagen, Biol Chem Hoppe Seyler 366) [12], Seite 1169-76.

Hartel Schenk, S.; Loch, N.; Zimmermann, M. und Reutter, W. (1991): Development of monoclonal antibodies against different protein and carbohydrate epitopes of dipeptidyl peptidase IV from rat liver plasma membranes, Eur J Biochem 196) [2], Seite 349-55.

Heymann, E.; Mentlein, R.; Nausch, J.; Erlanson-Albertson, C.; Yoshimoto, T. und Feller, A.C. (1986): Processing of procolipase and trypsinogen by pancreatic dipeptidyl peptidase IV, Biomed Biochim Acta 45), Seite 575-584.

Hildebrandt, M. (1994): Untersuchungen zur Dipeptidylpeptidase IV (DPP IV) im Verlauf der Differenzierung und Entdifferenzierung verschiedener Organe der Ratte, Fachbereich Grundlagenmedizin: Freie Universität Berlin Berlin.

Hildebrandt, M.; Arck, P.; Kruber, S.; Demuth, H.-U.; Reutter, W. und Klapp, B. F. (2001): Inhibition of Dipeptidyl Peptidase IV (DP IV, CD26) Activity Abrogates Stress-Induced, Cytokine-Mediated Murine Abortions, Scand J Immunol 53) [5], Seite 449-54.

Hildebrandt, M.; Bläser, F.; Beyer, J.; Siegert, W.; Mapara, M.; Huhn, D. und Salama, A. (1998): Detection of tumor cells in peripheral blood samples from patients with germ cell tumors using immunocytochemical and reverse transcriptase-polymerase chain reaction techniques, Bone Marrow Transplant 22), Seite 771-775.

Hildebrandt, M. und Mapara, M.Y. 1997:Verfahren zum Nachweis von kontaminierendem Karzinomzellen mittels Reverse Transkriptase-Polymerase Kettenreaktion (RT-PCR), Deutsches Patentamt Germany, Max Delbrück Centrum für Molekulare Medizin

Hildebrandt, M.; Mapara, M.Y.; Körner, I.J.; Bargou, R.C.; Moldenhauer, G. und Dörken, B. (1997): Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency., Exp Hematol 25), Seite 57-65.

Hildebrandt, M.; Reutter, W.; Arck, P.; Rose, M. und Klapp, B. F. (2000): A guardian angel: the involvement of dipeptidyl peptidase IV in psychoneuroendocrine function, nutrition and immune defence, Clin Sci (Colch) 99) [2], Seite 93-104.

Hildebrandt, M.; Reutter, W. und Gitlin, J. D. (1991): Tissue-specific regulation of dipeptidyl peptidase IV expression during development, Biochem J 277) [Pt 2], Seite 331-4.

Hildebrandt, M.; Rick, O.; Salama, A.; Siegert, W.; Huhn, D. und Beyer, J. (2000): Detection of germ-cell tumor cells in peripheral blood progenitor cell harvests: impact on clinical outcome, Clin Cancer Res 6) [12], Seite 4641-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11156214

Hildebrandt, M.; Rose, M.; Mayr, C.; Schüler, C.; Reutter, W.; Salama, A. und Klapp, B.F. (1999): Alterations in expression and in serum activity of Dipeptidyl Peptidase IV (DPP IV, CD26) in Patients with hyporectic eating disorders, Scand J Immunol 50) [5], Seite 536-541.

Hildebrandt, M.; Rose, M.; Mönnikes, H.; Reutter, W.; Keller, W. und Klapp, B.F. (2001): A role for Dipeptidyl peptidase IV (DP IV, CD26) in nutritional control, Nutrition 17) [6], Seite 451-4.

Hildebrandt, M.; Rose, M.; Rüter, J.; Salama, A.; Mönnikes, H. und Klapp, B.F. (2001): Dipeptidyl peptidase IV (DP IV, CD26) in patients with Inflammatory Bowel Disease, Scand J Gastroenterol 36) [12], Seite 1067-72.

Hildebrandt, M.; Serke, S.; Meyer, O.; Ebell, W. und Salama, A. (2000): Immunomagnetic selection of CD34+ cells: factors influencing component purity and yield, Transfusion 40) [5], Seite 507-12.

Holst, J. J. und Deacon, C. F. (1998): Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes, Diabetes 47) [11], Seite 1663-70.

[Seite 49↓]

Hopsu-Havu, V.K. und Glenner, G.G. (1966): A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-ß-naphthylamide, Histochemie 7), Seite 197-200.

Huss, R.; Gatsios, P.; Graeve, L.; Lange, C.; Eissner, G.; Kolb, H. J.; Thalmeier, K. und Heinrich, P. C. (2000): Quiescence of CD34-negative haematopoietic stem cells is mediated by downregulation of Cyclin B and no stat activation, Cytokine 12) [8], Seite 1195-204.

Husserl, E. (1996): Die Krisis der europäischen Wissenschaften und die transzendentale Phänomenologie: eine Einleitung in die phänomenologische Philosophie, Ströker, E., Meiner, Hamburg.

Imai, K.; Maeda, M.; Fujiwara, H.; Kariya, M.; Takakura, K.; Kanzaki, H. und Mori, T. (1992): Dipeptidyl peptidase IV as a differentiation marker of the human endometrial glandular cells, Hum Reprod 7) [9], Seite 1189-94.

Iwaki Egawa, S.; Watanabe, Y.; Kikuya, Y. und Fujimoto, Y. (1998): Dipeptidyl peptidase IV from human serum: Purification, characterization, and N-terminal amino acid sequence, J Biochem 124) [2], Seite 428-433.

Izbicki, J.R.; Hosch, S.B.; Pichlmeier, U.; Rehders, A.; Busch, C.; Niendorf, A.; Passlick, B.; Broelsch, C.E. und Pantel, K. (1997): Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer, N Engl J Med 337) [17], Seite 1188-1194.

Jacobson, L.O. (1952): Evidence for a humoral factor (or factors) concerned in recovery from radiation injury: a review, Cancer Res 12) [315-325].

Jacobson, L.O.; Simmons, E.L.; Marks, E.K. und Eldredge, J.H. (1951): Recovery from radiation injury, Science 113), Seite 510-511.

Jacotot, E.; Callebaut, C.; Blanco, J.; Riviere, Y.; Krust, B. und Hovanessian, A. G. (1996): HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells, Virology 223) [2], Seite 318-30.

Janssen, W. E.; Perkin, J. und Hiemenz, J. W. (1994): Granulocyte recovery is not different following auto-transplant with G-CDF primed bone marrow or G-CSF mobilized peripheral blood stem cells, Blood 84) [Suppl.], Seite 367A.

Juillerat Jeanneret, L.; Aubert, J. D. und Leuenberger, P. (1997): Peptidases in human bronchoalveolar lining fluid, macrophages, and epithelial cells: dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme), J Lab Clin Med 130) [6], Seite 603-14.

Kähne, T.; Lendeckel, U.; Wrenger, S.; Neubert, K.; Ansorge, S. und Reinhold, D. (1999): Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth, Int J Mol Med 4) [1], Seite 3-15.

Kähne, T.; Neubert, K. und Ansorge, S. (1995): Enzymatic activity of DPIV/CD26 is involved in PMA-induced hyperphosphorylation of p56lck, Immunol Lett 46) [1-2], Seite 189-193.

Kamori, M.; Hagihara, M.; Nagatsu, T.; Iwata, H. und Miura, T. (1991): Activities of dipeptidyl peptidase II, dipeptidyl peptidase IV, prolyl endopeptidase, and collagenase-like peptidase in synovial membrane from patients with rheumatoid arthritis and osteoarthritis, Biochem Med Metab Biol 45) [2], Seite 154-60.

Kaplan, E.L. und Meier, P. (1958): Non-parametric estimation from incomplete observations, J Am Stat Assoc 53), Seite 457-481.

Karydis, I. und Tolis, G. (1998): Orexis, anorexia, and thyrotropin-releasing hormone, Thyroid 8) [10], Seite 947-50.

Kennett, C. N.; Cox, S. W. und Eley, B. M. (1996): Histochemical and immunocytochemical localization of dipeptidyl peptidases II and IV in human gingiva, J Periodontol 67) [9], Seite 846-52.

Kieffer, T. J.; McIntosh, C. H. und Pederson, R. A. (1995): Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV, Endocrinology 136) [8], Seite 3585-96.

[Seite 50↓]

Korom, S.; De Meester, I.; Stadlbauer, T. H.; Chandraker, A.; Schaub, M.; Sayegh, M. H.; Belyaev, A.; Haemers, A.; Scharpe, S. und Kupiec Weglinski, J. W. (1997): Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients, Transplantation 63) [10], Seite 1495-500.

Kozakova, H.; Stepankova, R.; Kolinska, J.; Farre, M. A.; Funda, D. P.; Tuckova, L. und Tlaskalova Hogenova, H. (1998): Brush border enzyme activities in the small intestine after long-term gliadin feeding in animal models of human coeliac disease, Folia Microbiol Praha 43) [5], Seite 497-500.

Krause, D. S.; Fackler, M. J.; Civin, C. I. und May, W. S. (1996): CD34: structure, biology, and clinical utility, Blood 87) [1], Seite 1-13.

Kreisel, W.; Hildebrandt, H.; Mossner, W.; Tauber, R. und Reutter, W. (1993): Oligosaccharide reprocessing and recycling of a cell surface glycoprotein in cultured rat hepatocytes, Biol Chem Hoppe Seyler 374) [4], Seite 255-63.

Kreisel, W.; Reutter, W. und Gerok, W. (1984): Modification of the intramolecular turnover of terminal carbohydrates of dipeptidylaminopeptidase IV isolated from rat-liver plasma membrane during liver regeneration, Eur J Biochem 138) [3], Seite 435-8.

Krishnan, L.; Guilbert, L. J.; Wegmann, T. G.; Belosevic, M. und Mosmann, T. R. (1996): T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells, J Immunol 156) [2], Seite 653-62.

Laouar, A.; Wietzerbin, J. und Bauvois, B. (1993): Divergent regulation of cell surface protease expression in HL-60 cells differentiated into macrophages with granulocyte macrophage colony stimulating factor or neutrophils with retinoic acid, Int Immunol 5) [8], Seite 965-73.

Limpens, J.; de Jong, D.; van Krieken, J. H.; Price, C. G.; Young, B. D.; van Ommen, G. J. und Kluin, P. M. (1991): Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia, Oncogene 6) [12], Seite 2271-6..

Lin, H.; Mosmann, T. R.; Guilbert, L.; Tuntipopipat, S. und Wegmann, T. G. (1993): Synthesis of T helper 2-type cytokines at the maternal-fetal interface, J Immunol 151) [9], Seite 4562-73.

Lin, L.; Umahara, M.; York, D. A. und Bray, G. A. (1998): Beta-casomorphins stimulate and enterostatin inhibits the intake of dietary fat in rats, Peptides 19) [2], Seite 325-31.

Maes, M.; De Meester, I.; Scharpe, S.; Desnyder, R.; Ranjan, R. und Meltzer, H. Y. (1996): Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs, Acta Psychiatr Scand 93) [1], Seite 1-8.

Maes, M.; De Meester, I.; Vanhoof, G.; Scharpe, S.; Bosmans, E.; Vandervorst, C.; Verkerk, R.; Minner, B.; Suy, E. und Raus, J. (1991): Decreased serum dipeptidyl peptidase IV activity in major depression, Biol Psychiatry 30) [6], Seite 577-86.

Maes, M.; Lambrechts, J.; Bosmans, E.; Jacobs, J.; Suy, E.; Vandervorst, C.; de Jonckheere, C.; Minner, B. und Raus, J. (1992): Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining, Psychol Med 22) [1], Seite 45-53.

Maes, M.; Vandoolaeghe, E.; Ranjan, R.; Bosmans, E.; Van Gastel, A.; Bergmans, R. und Desnyder, R. (1996): Increased serum soluble CD8 or suppressor/cytotoxic antigen concentrations in depression: suppressive effects of glucocorticoids, Biol Psychiatry 40) [12], Seite 1273-81.

Mansi, J.L.; Berger, U.; Easton, D.; McDonnell, T.; Redding, W.H.; Gazet, J.C.; McKinna, A.; Powles, T.J. und Coombes, R.C. (1987): Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases, Br Med J (Clin Res Ed) 295), Seite 1093-6.

Mapara, M. Y.; Korner, I. J.; Hildebrandt, M.; Bargou, R.; Krahl, D.; Reichardt, P. und Dorken, B. (1997): Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction, Blood 89) [1], Seite 337-44.

[Seite 51↓]

Mapara, M.Y.; Körner, I.J.; Lentzsch, S.; Hildebrandt, M. und Dörken, B. (1999): Combined Positive/Negative Selection in Stem Cell Transplantation: Perspectives in Graft Engineering, Infusionsther Transfusionsmed 26) [3], Seite 140-145.

Marguet, D.; Bernard, A. M.; Vivier, I.; Darmoul, D.; Naquet, P. und Pierres, M. (1992): cDNA cloning for mouse thymocyte-activating molecule. A multifunctional ecto-dipeptidyl peptidase IV (CD26) included in a subgroup of serine proteases, J Biol Chem 267) [4], Seite 2200-2208.

Markert, U. R.; Arck, P. C.; McBey, B. A.; Manuel, J.; Croy, B. A.; Marshall, J. S.; Chaouat, G. und Clark, D. A. (1997): Stress triggered abortions are associated with alterations of granulated cells into the decidua, Am J Reprod Immunol 37) [1], Seite 94-100.

Masuyama, J.; Berman, J.S.; Cruikshank, W.W.; Morimoto, C. und Center, D.M. (1992): Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro, J Immunol 148) [5], Seite 1367-74.

Masuyama, J.; Yoshio, T.; Suzuki, K.; Kitagawa, S.; Iwamoto, M.; Kamimura, T.; Hirata, D.; Takeda, A.; Kano, S. und Minota, S. (1999): Characterization of the 4C8 antigen involved in transendothelial migration of CD26(hi) T cells after tight adhesion to human umbilical vein endothelial cell monolayers, J Exp Med 189) [6], Seite 979-90.

Mentlein, R. (1999): Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides, Regul Pept 85) [1], Seite 9-24.

Mentlein, R.; Gallwitz, B. und Schmidt, W.E. (1993): Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum, Eur J Biochem 214) [3], Seite 829-35.

Mentlein, R. und Roos, T. (1996): Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells, Peptides 17) [4], Seite 709-20.

Mizokami, A.; Eguchi, K.; Kawakami, A.; Ida, H.; Kawabe, Y.; Tsukada, T.; Aoyagi, T.; Maeda, K.; Morimoto, C. und Nagataki, S. (1996): Increased population of high fluorescence 1F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis, J Rheumatol 23) [12], Seite 2022-26.

Morimoto, C.; Lord, C. I.; Zhang, C.; Duke Cohan, J. S.; Letvin, N. L. und Schlossman, S. F. (1994): Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis, Proc Natl Acad Sci U S A 91) [21], Seite 9960-4.

Morimoto, C. und Schlossman, S. F. (1998): The structure and function of CD26 in the T-cell immune response, Immunol Rev 161), Seite 55-70.

Mrazkova, O.; Grim, M. und Carlson, B. M. (1986): Enzymatic heterogeneity of the capillary bed of rat skeletal muscles, Am J Anat 177) [2], Seite 141-8.

Murray, L.; Chen, B.; Galy, A.; Chen, S.; Tushinski, R.; Uchida, N.; Negrin, R.; Tricot, G.; Jagannath, S.; Vesole, D. und et al. (1995): Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood, Blood 85) [2], Seite 368-78.

Muscat, C.; Bertotto, A.; Agea, E.; Bistoni, O.; Ercolani, R.; Tognellini, R.; Spinozzi, F.; Cesarotti, M. und Gerli, R. (1994): Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients, Clin Exp Immunol 98) [2], Seite 252-6.

Myers, R. D. (1994): Neuroactive peptides: unique phases in research on mammalian brain over three decades, Peptides 15) [2], Seite 367-81.

Nausch, I.; Mentlein, R. und Heymann, E. (1990): The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta, Biol Chem Hoppe Seyler 371) [11], Seite 1113-8.

Newby, J.C.; A'Hern, R.P.; Leek, R.D.; Smith, I.E.; Harris, A.L. und Dowsett, M. (1995): Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: validation against ligand-binding assay and clinical relevance in breast cancer, Br J Cancer 71) [6], Seite 1237-1242.

Nichol, K.A.; Morey, A.; Couzens, M.H.; Shine, J.; Herzog, H. und Cunningham, A.M. (1999): Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control, J Neurosci 19) [23], Seite 10295-304.

[Seite 52↓]

Nielsen, O.H.; Vainer, B.; Madsen, S.M.; Seidelin, J.B. und Heegaard, N.H. (2000): Established and emerging biological activity markers of inflammatory bowel disease, Am J Gastroenterol 95) [2], Seite 359-67.

Nitsche, A.; Steuer, N..; Schmidt, C.A.; Landt, O.. und Siegert, W. (1999): Different Real-Time PCR Formats Compared for the Quantitative Detection of Human Cytomegalovirus DNA, Clin Chem 45) [11], Seite 1932-1937.

Olweus, J.; Thompson, P. A. und Lund-Johansen, F. (1996): Granulocytic and monocytic differentiation of CD34hi cells is associated with distinct changes in the expression of the PU.1-regulated molecules, CD64 and macrophage colony-stimulating factor receptor, Blood 88) [10], Seite 3741-54.

Oravecz, T.; Pall, M.; Roderiquez, G.; Gorrell, M. D.; Ditto, M.; Nguyen, N. Y.; Boykins, R.; Unsworth, E. und Norcross, M. A. (1997): Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage, J Exp Med 186) [11], Seite 1865-72.

Pantel, K.; Cote, R. J. und Fodstad, O. (1999): Detection and clinical importance of micrometastatic disease, J Natl Cancer Inst 91) [13], Seite 1113-24.

Pauly, R. P.; Rosche, F.; Wermann, M.; McIntosh, C. H.; Pederson, R. A. und Demuth, H. U. (1996): Investigation of glucose-dependent insulinotropic polypeptide-(1-42) and glucagon-like peptide-1-(7-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel kinetic approach, J Biol Chem 271) [38], Seite 23222-9.

Pederson, R. A.; White, H. A.; Schlenzig, D.; Pauly, R. P.; McIntosh, C. H. und Demuth, H. U. (1998): Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide, Diabetes 47) [8], Seite 1253-8.

Pesquero, J. B.; Jubilut, G. N.; Lindsey, C. J. und Paiva, A. C. (1992): Bradykinin metabolism pathway in the rat pulmonary circulation, J Hypertens 10) [12], Seite 1471-8.

Peters, W. P.; Rosner, G. und Ross, M. (1993): Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy, Blood 81), Seite 1709-1719.

Pettengell, R.; Morgenstern, G. R. und Woll, P. J. (1993): Peripheral blood progenitor cell transplantation in lymphoma and leukemia using single apheresis., Blood 82), Seite 3770-3777.

Piazza, G. A.; Callanan, H. M.; Mowery, J. und Hixson, D. C. (1989): Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix, Biochem J 262) [1], Seite 327-34.

Plana, M.; Vinas, O.; De la Calle Martin, O.; Lozano, F.; Ingles Esteve, J.; Romero, M.; Alberola Ila, J.; Yague, J.; Vilella, R. und Vives, J. (1991): Induction of interleukin 2 (IL 2) and interferon-gamma and enhancement of IL 2 receptor expression by a CD26 monoclonal antibody, Eur J Immunol 21) [4], Seite 1085-8.

Putz, E.; Witter, K.; Offner, S.; Stosiek, P.; Zippelius, A. und Johnson, J. (1999): Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases, Cancer Res 85), Seite 1419-1424.

Recktenwald, D.J. und Waller, E.K. (1996): Flow Cytometric Analysis, Morsty G und Sheridan W, Cell Therapy Stem Cell Transplantation, Gene Therapy and Cellular Immunotherapy, Seite 75, Cambridge University Press, New York, NY.

Reinhold, D.; Bank, U.; Buhling, F.; Lendeckel, U.; Faust, J.; Neubert, K. und Ansorge, S. (1997): Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells, Immunology 91) [3], Seite 354-60.

[Seite 53↓]

Reinhold, D.; Kahne, T.; Tager, M.; Lendeckel, U.; Buhling, F.; Bank, U.; Wrenger, S.; Faust, J.; Neubert, K. und Ansorge, S. (1997): The effect of anti-CD26 antibodies on DNA synthesis and cytokine production (IL-2, IL-10 and IFN-gamma) depends on enzymatic activity of DP IV/CD26, Adv Exp Med Biol 421), Seite 149-55.

Rill, D. R.; Santana, V. M.; Roberts, W. M.; Nilson, T.; Bowman, L. C.; Krance, R. A.; Heslop, H. E.; Moen, R. C.; Ihle, J. N. und Brenner, M. K. (1994): Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells, Blood 84) [2], Seite 380-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8025266

Ross, A.A.; Cooper, B.W.; Lazarus, B.M.; Mackay, W.; Moss, T.J.; Ciobanu, N.; Tallman, M.S.; Kennedy, M.J.; Davidson, N.E. und Sweet, D. (1993): Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques, Blood 82) [9], Seite 2605-2610.

Ruiz, P.; Hao, L.; Zucker, K.; Zacharievich, N.; Viciana, A. L.; Shenkin, M. und Miller, J. (1997): Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status, Transpl Immunol 5) [2], Seite 152-61.

Ruud, P.; Fodstad, O. und Hovig, E. (1999): Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells., Int J Cancer 80), Seite 119-125.

Satomura, K.; Derubeis, A. R.; Fedarko, N. S.; Ibaraki-O'Connor, K.; Kuznetsov, S. A.; Rowe, D. W.; Young, M. F. und Robey, P. G. (1998): Receptor Tyrosine Kinase Expression in Human Bone Marrow Stromal Cells, J Cell Physiol 177), Seite 426-438.

Schär, B. K.; Otto, V. I. und Hanseler, E. (1997): Simultaneous detection of all four alkaline phosphatase isoenzymes in human germ cell tumors using reverse transcription-PCR, Cancer Res 57) [17], Seite 3841-6.

Scheunemann, P.; Izbicki, J.R. und Pantel, K. (1999): Tumorigenic potential of apparently tumor-free lymph nodes, N Engl J Med 340), Seite 1687.

Schmitz, T.; Underwood, R.; Khiroya, R.; Bachovchin, W. W. und Huber, B. T. (1996): Potentiation of the immune response in HIV-1+ individuals, J Clin Invest 97) [6], Seite 1545-9.

Serke, S.; Beyer, J.; Rick, O.; Schwella, N.; Meyer, O.; Hildebrandt, M. und Huhn, D. (1998): Analysis of CD34-expressing cells in clinical practice, Vox Sang 74 Suppl 2), Seite 469-75.

Simon, B.; Podolsky, D.K.; Moldenhauer, G.; Isselbacher, K.J.; Gattoni-Celli, S. und Brand, S.J. (1990): Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein, Proc Natl Acad Sci U S A 87) [7], Seite 2755-2759.

Stancikova, M.; Lojda, Z.; Lukac, J. und Ruzickova, M. (1992): Dipeptidyl peptidase IV in patients with systemic lupus erythematosus, Clin Exp Rheumatol 10) [4], Seite 381-5.

Steeg, C.; Hartwig, U. und Fleischer, B. (1995): Unchanged signaling capacity of mutant CD26/dipeptidylpeptidase IV molecules devoid of enzymatic activity, Cell Immunol 164) [2], Seite 311-5.

Strober, W.; Fuss, I.J.; Ehrhardt, R.O.; Neurath, M.; Boirivant, M. und Ludviksson, B.R. (1998): Mucosal immunoregulation and inflammatory bowel disease: new insights from murine models of inflammation, Scand J Immunol 48) [5], Seite 453-8.

Struyf, S.; Proost, P.; Schols, D.; De Clercq, E.; Opdenakker, G.; Lenaerts, J. P.; Detheux, M.; Parmentier, M.; De Meester, I.; Scharpe, S. und Van Damme, J. (1999): CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3, J Immunol 162) [8], Seite 4903-9.

Suzuki, Y.; Erickson, R. H.; Sedlmayer, A.; Chang, S. K.; Ikehara, Y. und Kim, Y. S. (1993): Dietary regulation of rat intestinal angiotensin-converting enzyme and dipeptidyl peptidase IV, Am J Physiol 264) [6 Pt 1], Seite G1153-9.

[Seite 54↓]

Tanaka, S.; Murakami, T.; Horikawa, H.; Sugiura, M.; Kawashima, K. und Sugita, T. (1997): Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV, Int J Immunopharmacol 19) [1], Seite 15-24.

Tanaka, S.; Murakami, T.; Nonaka, N.; Ohnuki, T.; Yamada, M. und Sugita, T. (1998): Anti-arthritic effects of the novel dipeptidyl peptidase IV inhibitors TMC-2A and TSL-225, Immunopharmacology 40) [1], Seite 21-6.

Tanaka, T.; Duke Cohan, J. S.; Kameoka, J.; Yaron, A.; Lee, I.; Schlossman, S. F. und Morimoto, C. (1994): Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV, Proc Natl Acad Sci U S A 91) [8], Seite 3082-6.

Tanaka, T.; Kameoka, J.; Yaron, A.; Schlossman, S. F. und Morimoto, C. (1993): The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity, Proc Natl Acad Sci U S A 90) [10], Seite 4586-90.

Tiruppathi, C.; Miyamoto, Y.; Ganapathy, V. und Leibach, F. H. (1993): Genetic evidence for role of DPP IV in intestinal hydrolysis and assimilation of prolyl peptides, Am J Physiol 265) [1 Pt 1], Seite G81-9.

Uematsu, T.; Urade, M.; Yamaoka, M. und Yoshioka, W. (1996): Reduced expression of dipeptidyl peptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients, J Oral Pathol Med 25) [9], Seite 507-12.

Vanham, G.; Kestens, L.; De Meester, I.; Vingerhoets, J.; Penne, G.; Vanhoof, G.; Scharpe, S.; Heyligen, H.; Bosmans, E.; Ceuppens, J. L. und et al. (1993): Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects, J Acquir Immune Defic Syndr 6) [7], Seite 749-57.

von Bonin, A.; Huhn, J. und Fleischer, B. (1998): Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway, Immunol Rev 161) [Feb], Seite 43-53.

von Bonin, A.; Steeg, C.; Mittrucker, H. W. und Fleischer, B. (1997): The T-cell receptor associated zeta-chain is required but not sufficient for CD26 (dipeptidylpeptidase IV) mediated signaling, Immunol Lett 55) [3], Seite 179-82.

Walsh, D. A.; Mapp, P. I.; Wharton, J.; Polak, J. M. und Blake, D. R. (1993): Neuropeptide degrading enzymes in normal and inflamed human synovium, Am J Pathol 142) [5], Seite 1610-21.

Willheim, M.; Ebner, C.; Baier, K.; Kern, W.; Schrattbauer, K.; Thien, R.; Kraft, D.; Breiteneder, H.; Reinisch, W. und Scheiner, O. (1997): Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets, J Allergy Clin Immunol 100) [3], Seite 348-55.

Wilson, M. J.; Ruhland, A. R.; Pryor, J. L.; Ercole, C.; Sinha, A. A.; Hensleigh, H.; Kaye, K. W.; Dawkins, H. J.; Wasserman, N. F.; Reddy, P. und Ahmed, K. (1998): Prostate specific origin of dipeptidylpeptidase IV (CD-26) in human seminal plasma, J Urol 160) [5], Seite 1905-9.

Xiao, Q.; Boushey, R.P.; Cino, M.; Drucker, D.J. und Brubaker, P.L. (2000): Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease, Am J Physiol Regul Integr Comp Physiol 278) [4], Seite R1057-63.

Xu, B.; Kalra, P. S.; Moldawer, L. L. und Kalra, S. P. (1998): Increased appetite augments hypothalamic NPY Y1 receptor gene expression: effects of anorexigenic ciliary neurotropic factor, Regul Pept 75-76), Seite 391-5.

Xu, X. und Chong, A. S. (1995): Cross-linking of CD45 on NK cells stimulates p56lck-mediated tyrosine phosphorylation and IFN-gamma production, J Immunol 155) [11], Seite 5241-8.

Yamashita, K.; Tachibana, Y.; Matsuda, Y.; Katunuma, N.; Kochibe, N. und Kobata, A. (1988): Comparative studies of the sugar chains of aminopeptidase N and dipeptidylpeptidase IV purified from rat kidney brush border membrane, Biochemistry 27), Seite 5565-5573.

Yaron, A. und Naider, F. (1993): Proline-dependent structural and biological properties of peptides and proteins, Crit Rev Biochem Mol Biol 28) [1], Seite 31-81.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: